SLU-PP-332 Caps (500mcg)
SLU-PP-332 is a synthetic small-molecule research compound studied for its role in metabolic regulation and nuclear receptor signaling pathways. This capsule format delivers SLU-PP-332 in a stabilized oral dosage form for laboratory research use.
SLU-PP-332 is examined in laboratory settings for its connection to estrogen-related receptor (ERR) activation, which influences cellular energy metabolism and mitochondrial function.
GENIQ supplies SLU-PP-332 Caps strictly for laboratory research only—not for human or animal use.
$199.99
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is SLU-PP-332 Caps?
SLU-PP-332 is a synthetic small-molecule research compound studied for its role in metabolic regulation and nuclear receptor signaling pathways. This capsule format delivers SLU-PP-332 in a stabilized oral dosage form for laboratory research use. SLU-PP-332 is examined in laboratory settings for its connection to estrogen-related receptor (ERR) activation, which influences cellular energy metabolism and mitochondrial function. GENIQ supplies SLU-PP-332 Caps strictly for laboratory research only—not for human or animal use.
Peptide Overview
SLU-PP-332 is frequently studied in research focused on mitochondrial biology, fatty-acid oxidation, and skeletal muscle metabolism. In controlled laboratory environments, researchers examine how SLU-PP-332 Caps may promote changes in:
| Estrogen-related receptor (ERR) activation |
| Mitochondrial biogenesis signaling |
| Fatty-acid oxidation pathways |
| Skeletal muscle metabolic gene expression |
| Endurance-related signaling markers |
| Cellular energy utilization models |
| Exercise-mimetic research protocols |
All findings remain limited to preclinical and in-vitro experimental environments.
History of SLU-PP-332
SLU-PP-332 was developed by researchers at Saint Louis University as part of a program designing synthetic agonists for the estrogen-related receptors (ERRα, ERRβ, ERRγ). Scientists identified that activating these nuclear receptors could reproduce many of the cellular adaptations associated with aerobic exercise. Because of this interaction, SLU-PP-332 became a compound of interest in studies involving:
| Exercise-mimetic signaling research |
| Nuclear receptor pharmacology |
| Mitochondrial function studies |
| Metabolic syndrome research models |
| Skeletal muscle fiber-type studies |
| Endurance capacity research |
Peptide Structure
Chemical Name: SLU-PP-332 Classification: Synthetic ERRα/β/γ agonist (small molecule) Form Supplied: Oral capsule, 500mcg per capsule (100 capsules per bottle)
Certificates of Analysis
Every batch of GENIQ SLU-PP-332 Caps is verified by third-party laboratory testing confirming identity, purity, and capsule content accuracy. Certificates of Analysis (COA) are available upon request for research verification.
Research Findings
Research involving SLU-PP-332 commonly focuses on:
| ERR receptor activation: Studies evaluate how synthetic agonism of ERRα/β/γ affects gene transcription. |
| Mitochondrial biogenesis: Researchers investigate increases in mitochondrial density in skeletal muscle models. |
| Fatty-acid oxidation: Laboratory models track lipid metabolism changes following ERR activation. |
| Exercise capacity markers: Experimental studies analyze endurance-related adaptations without physical training. |
| Gene-expression modulation: Investigations explore transcriptional activity tied to metabolic pathways. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
FAQ
What type of research is SLU-PP-332 Caps used for?
SLU-PP-332 Caps is commonly used in studies involving mitochondrial biology, exercise-mimetic signaling, and metabolic research.
Does GENIQ provide a Certificate of Analysis?
Yes. Every GENIQ compound includes a COA verifying identity and purity.
Is SLU-PP-332 approved for human or veterinary use?
No. SLU-PP-332 is not FDA-approved and is intended strictly for laboratory research, not for human or animal administration.
Does GENIQ provide dosing or preparation instructions?
No. GENIQ does not provide dosing, administration, or preparation instructions, as our compounds are supplied strictly for laboratory research.
Who should handle this compound?
SLU-PP-332 Caps should only be handled by qualified researchers and laboratory professionals trained in proper handling procedures.
Research Use Only
All GENIQ compounds are intended strictly for laboratory research.
Not for human or animal consumption, medical use, or therapeutic application.
Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.
SLU-PP-332 is a synthetic small-molecule research compound studied for its role in metabolic regulation and nuclear receptor signaling pathways. This capsule format delivers SLU-PP-332 in a stabilized oral dosage form for laboratory research use.
SLU-PP-332 is examined in laboratory settings for its connection to estrogen-related receptor (ERR) activation, which influences cellular energy metabolism and mitochondrial function.
GENIQ supplies SLU-PP-332 Caps strictly for laboratory research only—not for human or animal use.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.